Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

NeuroPace (NPCE) Leases (2022 - 2026)

NeuroPace has reported Leases over the past 5 years, most recently at $9.7 million for Q1 2026.

  • For Q1 2026, Leases fell 15.32% year-over-year to $9.7 million; the TTM value through Mar 2026 reached $9.7 million, down 15.32%, while the annual FY2025 figure was $10.1 million, 14.45% down from the prior year.
  • Leases for Q1 2026 was $9.7 million at NeuroPace, down from $10.1 million in the prior quarter.
  • Over five years, Leases peaked at $15.1 million in Q3 2022 and troughed at $5.0 million in Q2 2022.
  • A 5-year average of $11.7 million and a median of $12.2 million in 2024 define the central range for Leases.
  • Biggest five-year swings in Leases: skyrocketed 183.51% in 2023 and later fell 15.32% in 2026.
  • Year by year, Leases stood at $14.8 million in 2022, then fell by 9.66% to $13.4 million in 2023, then dropped by 11.65% to $11.8 million in 2024, then fell by 14.45% to $10.1 million in 2025, then dropped by 4.47% to $9.7 million in 2026.
  • Business Quant data shows Leases for NPCE at $9.7 million in Q1 2026, $10.1 million in Q4 2025, and $10.6 million in Q3 2025.